Is there a role of the histologic subtypes of papillary renal cell carcinoma as a prognostic factor?

Japanese Journal of Clinical Oncology

Volumn 39, Issue 10, 2009, Pages 664-670

  Ku, Ja Hyeon ^a   Moon, Kyung Chul ^a   Kwak, Cheol ^a,b   Kim, Hyeon Hoe ^a   Lee, Sang Eun ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Kidney neoplasm; Papillary renal cell carcinoma; Prognosis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PREDICTION; PROGNOSIS; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR CLASSIFICATION; TUMOR NECROSIS; TUMOR VOLUME; DISEASE FREE SURVIVAL; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 70349971911     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp075     Document Type: Article

References (22)

1. Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002;26:281-91.
2. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol 2005;23:2763-71.
3. Delahunt B, Eble JN. Papillary renal cell carcinoma: A clinopathologic and immunohistochemical study of 105 tumors. Mol Pathol 1997;10:537-44.
4. Jiang F, Richter J, Schraml P, Bubendorf L, Gasser T, Sauter G, et al. Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol 1998;153:1467-73.
5. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: A Swiss experience with 588 tumors. Cancer 2000;89:604-14.
6. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001;32:590-5.
7. Leroy X, Zini L, Leteurtre E, Zerimech F, Porchet N, Aubert JP, et al. Morphologic subtyping of papillary renal cell carcinoma: Correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002;15:1126-30.
8. Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A. Papillary renal cell carcinoma: Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 2003;442:336-42.
9. Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chretien Y, et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: Meaning of histological typing and multifocality. J Urol 2003;170:764-7.
10. Pignot G, Elie C, Conguy S, Vieillefond A, Flam T, Zerbib M, et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 type 2 subclassification. Urology 2007;69:230-5.
11. Yamanaka K, Miyake H, Hara I, Inoue TA, Hanioka K, Fujisawa M. Papillary renal cell carcinoma: A clinicopathological study of 35 cases. Int J Urol 2006;13:1049-52.
12. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th edn. New York: Wiley-Liss Inc. 2002.
13. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
14. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:987-9.
15. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27:612-24.
16. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: A retrospective nationwide study of 629 patients. Eur Urol 2005;48: 593-600.
17. Beck SD, Patel MI, Snyder ME, Kattan MW, Motzer RJ, Reuter VE, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 2004;11:71-7.
18. Ljungberg B, Alamdari FI, Stenling R, Roos G. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999;36:565-9.
19. Kim H, Cho NH, Kim DS, Kwon YM, Kim EK, Rha SH, et al. Renal cell carcinoma in South Korea: A multicenter study. Hum Pathol 2004;35:1556-63.
20. Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006;30:1091-6.
21. Ficarra V, Schips L, Guille F, Li G, De La Taille A, Praver Galetti T, et al. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer 2005;104:968-74.
22. Delahunt B, Kittelson JM, McCredie MR, Reeve AE, Stewart JH, Bilous AM. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: Assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 2002;94:659-64.